Overcoming trastuzumab resistance in HER2‐positive breast cancer using combination therapy - Derakhshani, Afshin; Rezaei, Zohreh; Safarpour, Hossein; Sabri, Morteza; Mir, Atefeh; Sanati, Mohammad Amin; Vahidian, Fatemeh; Gholamiyan Moghadam, Ali; Aghadoukht, Ali; Hajiasgharzadeh, Khalil; Baradaran, Behzad (Journal of cellular physiology, 2020)
Keywords: Antineoplastic Agents - pharmacology; Breast cancer; Breast Neoplasms - drug therapy; Breast Neoplasms - metabolism; Combination therapy; drug resistance; Drug Resistance, Neoplasm - drug effects; Epidermal growth factor; ErbB-2 protein; Growth factors; HER2 positive; Humans; Immunotherapy; Lapatinib - therapeutic use; Monoclonal antibodies; Receptor, ErbB-2 - drug effects; Targeted cancer therapy; Trastuzumab; Trastuzumab - therapeutic use; trastuzumab; HER2 positive; breast cancer; drug resistance